What is a stock summary page? Click here for an overview.
Business Description
Talis Biomedical Corp
NAICS : 339112
SIC : 3845
ISIN : US87424L2079
Share Class Description:
TLIS: Ordinary SharesDescription
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.18 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | -0.35 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -12.14 | |||||
| Beneish M-Score | -7.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.2 | |||||
| 3-Year EPS without NRI Growth Rate | 21.1 | |||||
| 3-Year FCF Growth Rate | 25.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.38 | |||||
| 9-Day RSI | 22.88 | |||||
| 14-Day RSI | 32.99 | |||||
| 3-1 Month Momentum % | -9.68 | |||||
| 6-1 Month Momentum % | -5.62 | |||||
| 12-1 Month Momentum % | -80.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.76 | |||||
| Quick Ratio | 7.76 | |||||
| Cash Ratio | 7.3 | |||||
| Days Sales Outstanding | 175.2 | |||||
| Days Payable | 50866.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.6 | |||||
| Shareholder Yield % | 190.81 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 93.33 | |||||
| Operating Margin % | -18374 | |||||
| Net Margin % | -17008.67 | |||||
| FCF Margin % | -13411.67 | |||||
| ROE % | -72.45 | |||||
| ROA % | -53.13 | |||||
| ROIC % | -268.84 | |||||
| 3-Year ROIIC % | -97.68 | |||||
| ROC (Joel Greenblatt) % | -397.79 | |||||
| ROCE % | -63.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.43 | |||||
| PB Ratio | 0.06 | |||||
| Price-to-Tangible-Book | 0.06 | |||||
| EV-to-EBIT | 0.69 | |||||
| EV-to-EBITDA | 0.7 | |||||
| EV-to-Revenue | -127.43 | |||||
| EV-to-FCF | 0.94 | |||||
| Price-to-Net-Current-Asset-Value | 0.07 | |||||
| Price-to-Net-Cash | 0.08 | |||||
| Earnings Yield (Greenblatt) % | 144.93 | |||||
| FCF Yield % | -1419.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TLIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Talis Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.3 | ||
| EPS (TTM) ($) | -28.02 | ||
| Beta | 1.49 | ||
| 3-Year Sharpe Ratio | -0.82 | ||
| 3-Year Sortino Ratio | -1.02 | ||
| Volatility % | 74.16 | ||
| 14-Day RSI | 32.99 | ||
| 14-Day ATR ($) | 0.065127 | ||
| 20-Day SMA ($) | 1.6585 | ||
| 12-1 Month Momentum % | -80.07 | ||
| 52-Week Range ($) | 1.04 - 9.6 | ||
| Shares Outstanding (Mil) | 1.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Talis Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Talis Biomedical Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Talis Biomedical Corp Frequently Asked Questions
What is Talis Biomedical Corp(TLIS)'s stock price today?
The current price of TLIS is $1.56. The 52 week high of TLIS is $9.60 and 52 week low is $1.04.
When is next earnings date of Talis Biomedical Corp(TLIS)?
The next earnings date of Talis Biomedical Corp(TLIS) is 2025-05-08 Est..
Does Talis Biomedical Corp(TLIS) pay dividends? If so, how much?
Talis Biomedical Corp(TLIS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers